Matthew Kapalis, DO
Clinical Cardiac Electrophysiology · Omaha, NENPI 1003058173
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Biosense Webster, Inc. at 45.4% of the total. 2025 is the largest year on record at $10,412, 6.0 times the $1,737 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NE, where the typical reported total is $23,571.
Across 381 payments — averaging $61.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$11K
- Medtronic$10K
- Boston Scientific$3K
- Edwards Lifesciences$144
- Johnson & Johnson$89
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$79
- plus $420 from 14 others
What the payments were for
- Consulting fees$8,25035%
- Travel & lodging$8,07134%
- Food & beverage$7,25031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 226 | $10,712 |
| Medtronic(2 entities) | 83 | $9,602 |
| Boston Scientific | 27 | $2,525 |
| Edwards Lifesciences | 4 | $144 |
| Johnson & Johnson | 6 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $79 |
| E.r. Squibb & Sons, L.L.C. | 5 | $68 |
| Pfizer | 5 | $66 |
| Abbott | 2 | $64 |
| Boehringer Ingelheim | 3 | $37 |
| United Therapeutics Corporation | 1 | $27 |
| Impulse Dynamics (USA) Inc. | 1 | $25 |
| Altathera Pharmaceuticals LLC | 1 | $24 |
| Philips North America LLC | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Terumo Medical Corporation | 1 | $12 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$2,671
- Micra$1,216
- EVERA MRI XT DR SURESCAN$1,061
- INGEVITY$632
- AURORA EV-ICD MRI SURESCAN$323
- AZURE XT DR MRI SURESCAN$291
- NUVISION ICE CATHETER$267
- QDOT MICRO$253
- LINQ II$145
- OCTARAY MAPPING CATHETER$126
- Azure$104
- CLARIA MRI QUAD CRT-D SURESCAN$104
How this compares
$23,571 in reported general payments places this provider in the 50th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
See all clinical cardiac electrophysiology providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 174 | $144,934 |
| EliquisApixaban | 137 | $113,661 |
| MultaqDronedarone Hcl | 27 | $35,232 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $2,224 |
| Metoprolol Succinate | 224 | $2,068 |
| Midodrine Hcl | 23 | $901 |
| Droxidopa | 11 | $829 |
| Bisoprolol Fumarate | 14 | $783 |
| Nebivolol Hcl | 13 | $591 |
| Amiodarone Hcl | 50 | $591 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 37 | $569 |
| Propafenone Hcl | 23 | $548 |
| SotalolSotalol Hcl | 18 | $473 |
| Amlodipine Besylate | 59 | $392 |
| Pantoprazole Sodium | 46 | $315 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $89 | $144,934174 claims |
| PfizerEliquis | $66 | $113,661137 claims |
| Sanofi-aventis U.S. LLCMultaq | $17 | $35,23227 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
Other clinical cardiac electrophysiology in Omaha
- Hussam AbuissaOmaha$162K
- Jeffrey MahoneyOmaha$118K
- Shane TsaiOmaha$68K
- Jason PayneOmaha$59K
- Matthew SorensenOmaha$30K
- David SternsOmaha$28K
- Christopher EricksonOmaha$18K
- Matthew LatachaOmaha$14K
- Daniel VariOmaha$9K
- John SchleiferOmaha$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.